Abstract
Erythromycin was found to be a more effective inhibitor of gram-negative bacilli in alkaline medium than in neutral or acid medium. A definite effect was noted with all of 500 recent clinical isolates of Escherichia coli, Klebsiella-Enterobacter, Pseudomonas aeruginosa, and Proteus mirabilis studied, but it was most striking with E. coli. At pH 8.5 all strains, except for 14% of those of P. mirabilis, were inhibited by concentrations of erythromycin readily achieved in urine with common therapeutic doses.
MeSH Terms
Bacteriuria/drug therapy
Drug Resistance, Microbial
Enterobacteriaceae/drug effects
Erythromycin/administration & dosage,pharmacology
Humans
Hydrogen-Ion Concentration
Microbial Sensitivity Tests
Pseudomonas aeruginosa/drug effects
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lorian V
Sabath L D
References (6)
6 references, click to expand
-
Behaviour in vitro of some new antistaphylococcal antibiotics.
Br Med J. 1956 Jul 14;2(4984):61-5
PMID: 13329383
-
The susceptibility of coliform bacilli to erythromycin.
Antibiot Chemother (Northfield). 1962 Mar;12:169-72
PMID: 14007243
-
Routine titrations of Lansing virus and antibody in mice: comparison of methods of estimating endpoints.
Proc Soc Exp Biol Med. 1952 Oct;81(1):118-21
PMID: 13047332
-
Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.
Appl Microbiol. 1968 Sep;16(9):1288-92
PMID: 4970991
-
Erythromycin plus alkalinization in treatment of urinary infections.
Antimicrob Agents Chemother (Bethesda). 1969;9:413-6
PMID: 5396518
-
Sensitivity of E. coli, Ps. aeruginosa and B. proteus to erythromycin in various pH culture media.
Chemotherapia (Basel). 1963;6:82-9
PMID: 14003017